Abstract
Sickle cell disease is a genetic disorder of red blood cells that predisposes patients to acute and chronic pain. Acute pain crises, or vaso-occlusive crises, should be treated expeditiously to avoid other complications of sickle cell disease. Management of crises includes supportive care as well as multimodal analgesia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–48.
Yusuf HR, Altrash HK, Grosse SD, et al. Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999–2007. Am J Prev Med. 2010;38(4 Suppl):S536–41.
McClish DK, Smith WR, Dahman BA, et al. Pain site frequency and location in sickle cell disease: the PiSCES project. Pain. 2009;145(1–2):246–51.
Niscola P, Sorrentino F, Scaramucci L, et al. Pain syndromes in sickle cell disease: an update. Pain Med. 2009;10(3):470–80.
Beers EJ, van Tuijn CF, Nieuwkerk PT, et al. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol. 2007;82(11):955–60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fischer, M., Sachdeva, H., Abd-Elsayed, A. (2019). Sickle Cell Disease. In: Abd-Elsayed, A. (eds) Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-99124-5_274
Download citation
DOI: https://doi.org/10.1007/978-3-319-99124-5_274
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99123-8
Online ISBN: 978-3-319-99124-5
eBook Packages: MedicineMedicine (R0)